Longitudinal [18F]-FDG PET Characterization of Alzheimer's Disease P301S Transgenic Mice

被引:0
|
作者
Garcia-Varela, L. [1 ,2 ,3 ]
Custodia, A. [3 ,4 ]
Barro Rico, L. [1 ,3 ]
Gomez Lado, N. [1 ,3 ]
Codesido, J. [2 ,3 ,5 ]
Cuartero, A. [5 ]
Fernandez-Ferreiro, A. [5 ]
Sanjurjo, D. Romaus [3 ,4 ]
Ouro, A. [3 ,4 ]
Sobrino, T. [3 ,4 ]
Aguiar, P. [1 ,2 ,3 ]
机构
[1] USC, Mol Imaging & Pharmacokinet Modelling Grp, CIMUS, Santiago De Compostela, Spain
[2] Univ Clin Hosp, Nucl Med & Mol Imaging Grp, IDIS, Santiago De Compostela, Spain
[3] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain
[4] IDIS, NeuroAging Grp NEURAL, Clin Neurosci Res Lab LINC, Santiago De Compostela, Spain
[5] Univ Clin Hosp Santiago De Compostela, Pharmacol Grp, IDIS, Santiago De Compostela, Spain
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
EP-0023
引用
收藏
页码:S440 / S440
页数:1
相关论文
共 50 条
  • [1] Early behavioural markers of disease in P301S tau transgenic mice
    Scattoni, Maria Luisa
    Gasparini, Laura
    Alleva, Enrico
    Goedert, Michel
    Calamandrei, Gemma
    Spillantini, Maria Grazia
    BEHAVIOURAL BRAIN RESEARCH, 2010, 208 (01) : 250 - 257
  • [2] [18F]FDG-PET in patients with Alzheimer's disease:: Marker of disease spread
    Bittner, D
    Grön, G
    Schirrmeister, H
    Reske, SN
    Riepe, MW
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2005, 19 (01) : 24 - 30
  • [3] Longitudinal florzolotau (18F) PET study in a rat model of Alzheimer's disease
    Moreno, Oscar
    Martin, Abraham
    Scholl, Michael
    Roig, Jordi Llop
    NUCLEAR MEDICINE AND BIOLOGY, 2023, 126 : S115 - S116
  • [4] Piericidin A Aggravates Tau Pathology in P301S Transgenic Mice
    Hoellerhage, Matthias
    Deck, Roman
    De Andrade, Anderson
    Respondek, Gesine
    Xu, Hong
    Rosler, Thomas W.
    Salama, Mohamed
    Carlsson, Thomas
    Yamada, Elizabeth S.
    El Hak, Seham A. Gad
    Goedert, Michel
    Oertel, Wolfgang H.
    Hoeglinger, Guenter U.
    PLOS ONE, 2014, 9 (12):
  • [5] [18F]FDG-PET study in dementia with Lewy bodies and Alzheimer's disease
    Okamura, N
    Arai, H
    Higuchi, M
    Tashiro, M
    Matsui, T
    Hu, XS
    Takeda, A
    Itoh, M
    Sasaki, H
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2001, 25 (02): : 447 - 456
  • [6] Fenazaquin aggravates tau pathology in P301S transgenic mice
    Salama, Mohamed M.
    Roesler, Thomas W.
    El Hak, Seham Gad
    Hoeglinger, Gunter U.
    NEUROTOXICOLOGY AND TERATOLOGY, 2015, 49 : 124 - 125
  • [7] Doubly Phosphorylated Peptide Vaccines to Protect Transgenic P301S Mice against Alzheimer's Disease Like Tau Aggregation
    Richter, Monique
    Mewes, Agneta
    Fritsch, Manuela
    Kruegel, Ute
    Hoffmann, Ralf
    Singer, David
    VACCINES, 2014, 2 (03): : 601 - 623
  • [8] PET and 18F ligands in the diagnosis of Alzheimer's disease
    Frisoni, Giovanni B.
    LANCET NEUROLOGY, 2011, 10 (05): : 397 - 399
  • [9] Role of [18F]FDG and [18F]Florbetapir PET/CT to predict Alzheimer's disease development in patients with Down syndrome
    Abouzian, S.
    Valverde, R.
    Pegueroles, J.
    Sizova, M.
    Fuentes, F.
    Fernandez, A.
    Duch, J.
    Lopez-Mora, D.
    Estorch, M.
    Barroeta, I.
    Carmona-Iragui, M.
    Lleo, A.
    Carrio, I.
    Flotats, A.
    Fortea, J.
    Camacho, V.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S297 - S297
  • [10] Limitations of Small Animal PET Imaging with [18F]FDDNP and FDG for Quantitative Studies in a Transgenic Mouse Model of Alzheimer's Disease
    Kuntner, Claudia
    Kesner, Adam L.
    Bauer, Martin
    Kremslehner, Robert
    Wanek, Thomas
    Mandler, Markus
    Karch, Rudolf
    Stanek, Johann
    Wolf, Tanja
    Mueller, Markus
    Langer, Oliver
    MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (04) : 236 - 240